Strategic Publication Planning

$22,000

GPP 2022-compliant 2-3 year publication strategy development. Clinical program mapping, journal targeting, author engagement, and regulatory alignment. Comprehensive planning document with Gantt timeline.

SKU: EV-MC-008 Category:

Description

Strategic Publication Planning

A comprehensive 2-3 year publication strategy aligned with your clinical development and commercial objectives. GPP 2022-compliant planning sets out which data will be published, when and where, and who will author it — supporting ethical, transparent scientific communication.

Service Details

Planning horizon 2-3 years
Turnaround Initial Plan: 6-8 weeks | Annual Update: 3-4 weeks
Planning scope Single product, portfolio, or launch
Main deliverable Comprehensive publication plan document with a publication matrix (Gantt timeline)

Compliance Framework

  • GPP 2022 – Publication planning ethics
  • ICMJE – Trial registration and reporting
  • COPE – Responsible publication practices
  • PhRMA/EFPIA – Industry transparency codes

Publication Plan Components

  • Clinical program mapping
  • Data availability timeline
  • Target journal identification
  • Congress strategy
  • Author identification and engagement
  • Competitive landscape analysis
  • Regulatory submission alignment
  • Launch timing integration

Deliverables

  • Comprehensive publication plan document
  • Publication matrix (Gantt timeline)
  • Journal target analysis
  • Author engagement tracker
  • Budget and resource projections
  • Risk mitigation strategies
  • Quarterly review cadence

Planning Scope

  • Single Product: Individual asset publication strategy
  • Portfolio: Multiple products/indications
  • Launch: Approval-focused publication surge

How It Works

  1. Share your clinical development program, available and expected data, and commercial objectives
  2. We map the clinical program and competitive landscape and identify target journals, congresses and authors
  3. You review the draft publication plan and we revise it based on your feedback
  4. You receive the final plan document, publication matrix and supporting trackers, with a quarterly review cadence

Which Service Do You Need?

This service builds the plan. To develop the individual publications in it, see Primary Manuscript Development (Phase 2/3) for pivotal trial results, Secondary & Post-Hoc Analysis Manuscripts for subgroup, exploratory and post-hoc analyses, or Scientific Congress Abstract for congress submissions.

Frequently Asked Questions

What period does the publication plan cover?
A 2-3 year publication strategy, aligned with your clinical development and commercial objectives.

How long does planning take?
The initial plan takes 6-8 weeks. An annual update takes 3-4 weeks.

Can the plan cover more than one product?
Yes. Planning scope can be a single product (individual asset publication strategy), a portfolio (multiple products/indications), or a launch (approval-focused publication surge).

What do we receive?
A comprehensive publication plan document, a publication matrix (Gantt timeline), journal target analysis, an author engagement tracker, budget and resource projections, risk mitigation strategies, and a quarterly review cadence.

Which guidelines and codes does the planning follow?
GPP 2022 publication planning ethics, ICMJE trial registration and reporting, COPE responsible publication practices, and the PhRMA/EFPIA industry transparency codes.

Get started: add this service to your cart, or email co*****@*******se.com to discuss your clinical program and planning scope.